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BY KEITH H. BRIDWELL, MD, PAUL A. ANDERSON, MD, SCOTT D. BODEN, MD, 
ALEXANDER R. VACCARO, MD, AND JACK E. ZIGLER, MD
Spinal Deformity Surgery
The Scoliosis Research Society (SRS) was founded in 1966 with 
a principal interest in pediatric spinal deformity. Quite a bit 
has changed since then, and the main interest is no longer sim-
ply teenage idiopathic scoliosis. Other interests and concerns 
include adult deformity, tumors, fractures, and spondylolis-
thesis, which are conditions that can affect patients throughout 
life. The current mission statement of the Scoliosis Research 
Society is “to foster optimal care of the patient with any disor-
der that may affect the shape, alignment or function of the 
spine, throughout life. The SRS accomplishes this, through 
education, research, advocacy and ethical practice.”
Idiopathic Scoliosis
It is debatable whether lumbar and thoracolumbar curves are 
best treated surgically through an anterior or a posterior ap-
proach. Problems that have been associated with anterior 
treatment in the past have included loss of segmental lordosis 
and early failure of the implants. However, three studies that 
were presented at the Scoliosis Research Society meeting in 
Quebec City in September 2003 suggested that modern ante-
rior instrumentation is associated with better results. The 
use of solid-rod implants with structural interbody anterior-
column support and/or a two-screw two-rod technique re-
portedly leads to better correction of the curvature, fewer 
levels being fused, and better “spontaneous correction” of 
adjacent curves. 
Posterior surgical methods for the treatment of thoracic 
and double-major curves are tending toward the use of seg-
mental pedicle-screw fixation. The use of screws allows for 
improved segmental purchase and appears to offer potentially 
greater coronal, sagittal, and apical correction. This greater 
correction may allow surgeons to fuse fewer spinal segments 
in selected cases. However, the surgical technique of thoracic 
pedicle screw placement has to be precise. Although greater 
correction is possible, the potential for catastrophe (e.g., plac-
ing the screws into the spinal cord or the great vessels) remains 
a great concern.
We continue to be very interested in long-term studies 
on the natural history of untreated idiopathic scoliosis. It is 
very difficult to find a substantial cohort of patients. Previous 
studies have suggested that curves of >50° have a high propen-
sity for progression into adulthood. In a study from the Twin 
Cities Spine Center in Minneapolis, Minnesota, a total of 
forty-six patients with curves of 30° to 50° were followed for at 
least ten years after skeletal maturity. The investigators found 
that these curves progressed an average of 0.5° per year. How-
ever, only 4% of the curves progressed >1° per year, and only 
two patients “required” posterior spinal fusion. Therefore, it 
would appear that the prognosis for curves of 30° to 50° is bet-
ter than that for larger curves.
Adult Spinal Deformity
Several studies have analyzed the validity of the SRS-22 ques-
tionnaire as an outcome instrument for the assessment of ado-
lescent idiopathic scoliosis. Studies that are now emerging 
have suggested that this instrument is valid for the evaluation 
of adult spinal deformity.
The treatment of adult spinal deformity is more com-
plex than the treatment of adolescent deformity and is associ-
ated with a higher rate of complications. In both adolescents 
and adults, there is a certain prevalence of proximal junctional 
kyphosis cephalad to the fusion. This is a topic about which 
we are just starting to scratch the surface, and additional stud-
ies are needed to analyze risk factors and the consequences of 
cephalad junctional deformity. 
In many adults in whom lumbar scoliosis is the princi-
pal abnormality, there is rotatory subluxation at L3-L4 and 
fixed tilt at L4-L5. In these cases, a decision has to be made 
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about whether to stop the fusion at L5 or at the sacrum. It 
would appear that stopping the fusion at L5 would be associ-
ated with fewer short-term complications, but investigators 
have reported a relatively high prevalence of later breakdown 
(kyphosis and accelerated disc degeneration) at L5-S1 with a 
subsequent need to extend the fusion to the sacrum. There-
fore, controversy remains regarding the indications for stop-
ping the fusion at L5 as opposed to the sacrum. Additional 
multicenter work is required in this area in order to achieve 
universal agreement.
It is also apparent that the risk of pseudarthrosis follow-
ing a long fusion is much greater in adults than it is in teen-
agers. Furthermore, teenagers usually tolerate aggressive 
anterior surgery well whereas adults have a higher prevalence 
of postoperative pulmonary complications following tran-
sthoracic and thoracoabdominal approaches. One study from 
the Twin Cities Spine Center assessed the relationship between 
the rate of complications and the age of the patient. The inves-
tigators concluded that, although the number of complica-
tions in the elderly population was high, comorbidities were 
a more important factor for assessing risk than was patient 
age per se. 
Surgical Complications
One of the most devastating complications of spinal defor-
mity surgery is a major neurological deficit. Studies presented 
at the recent Scoliosis Research Society meeting in Quebec 
City indicated that the patients who are at highest risk are 
those with congenital spinal deformities and spinal stenosis 
with osseous dysplasia, those undergoing combined anterior 
and posterior procedures, adults undergoing revision surgery 
for the treatment of kyphosis, and those undergoing proce-
dures in which multiple segmental vessels are harvested on the 
left side of the spine. Following a major perioperative neuro-
logical deficit, many patients demonstrate some return of 
function but few have complete recovery. 
Spondylolisthesis
The Morbidity and Mortality Committee of the SRS has ana-
lyzed trends within the society with regard to the treatment of 
spondylolisthesis. For high-grade spondylolisthesis, there has 
been a trend toward more reduction, circumferential fusion, 
and instrumentation. For medium-grade spondylolisthesis in 
adults, it is also now more common to perform posterior in-
strumentation and circumferential fusion. It is believed that 
these techniques lead to a higher rate of fusion and a better 
outcome, although the more invasive the method used, the 
higher the neurological risks. The greatest neurological risk 
associated with aggressive treatment of spondylolisthesis con-
tinues to be foot drop.
Spinal Deformity Subspecialty Certification
On three occasions, the Board of Directors of the Scoliosis Re-
search Society has endorsed the concept of applying for sub-
specialty certification through the American Board of 
Orthopaedic Surgery and the American Board of Medical 
Specialties. The potential benefits include improving the 
education of spine surgeons, as most spine fellowships cur-
rently do not focus on the full spectrum of spinal surgery. 
Quite a bit of work has been done in this regard, and an ini-
tial application has been made. This issue is highly conten-
tious. Although most spine surgeons agree that subspecialty 
certification would improve surgeon education and patient 
care, this process is associated with many practice concerns 
and inconveniences that will have to be resolved. Whether it 
will become a reality for the field of spinal deformity remains 
to be seen.
The Cervical Spine
A paradigm change from fusion to motion preservation is 
occurring in the treatment of cervical spine disorders. In the 
United States, three cervical disc prostheses are currently un-
der investigation in approved studies. The theoretical advan-
tages of disc replacement are to prevent adjacent segment 
degeneration, to maintain cervical motion, to avoid compli-
cations related to fusion (such as pseudarthrosis, implant-
related effects, and bone-graft morbidity), and to allow earlier 
return to activities. There have been no long-term follow-up 
studies thus far, and one should use caution when interpreting 
short-term results.
Justification for Disc Arthroplasty
Effects of Fusion
Anterior cervical fusion is a well-accepted procedure that is 
associated with a high rate of satisfactory results. However, 
long-term studies have shown a 25% prevalence of adjacent-
segment symptoms within ten years. Researchers in Belgium 
recently presented additional evidence on the long-term ad-
verse effects of cervical fusion. At a minimum of five years 
after cervical fusion, 92% of 120 patients had new-onset or 
progressive degenerative changes at adjacent levels. There was 
no significant difference between patients with traumatic and 
spondylotic etiologies with regard to the development of de-
generative changes. This finding suggests that the interbody 
fusion acts as a triggering factor. Findings that were presented 
at the 2003 Annual Meeting of the Cervical Spine Research 
Society confirmed these observations. Disc pressures at adja-
cent segments were found to be significantly increased. With 
use of a finite-element model, a 20% to 30% increase in flex-
ion-extension and rotation was noted adjacent to fused levels. 
This increase in motion more than doubled after two-level 
fusions. 
In Vivo and In Vitro Analysis 
of Disc Arthroplasty
Kinematic studies have confirmed that disc replacement nor-
malizes motion compared with fusion. In a biomechanical 
study, no differences in flexion-extension or coupled motions 
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were observed at adjacent segments before or after disc re-
placement. Researchers from both Belgium and Denver, 
Colorado, evaluated adjacent-segment motion with use of 
cinefluoroscopy in ten normal individuals, ten patients with 
C5-C6 spondylosis, ten patients with a C5-C6 fusion, and 
ten patients with a C5-C6 disc replacement. The adjacent-
segment motion was normalized following disc replacement. 
Compared with the patients with spondylosis and the patients 
with fusion, the patients with disc replacement had normal, 
synchronous patterns during motion.
Early Clinical Results of Disc Arthroplasty
The short-term results of disc arthroplasty have been reported 
to be equivalent to those of fusion. In one European study, 
eighty-three patients who had been treated with the Bryan 
disc were evaluated after a minimum duration of follow-up 
of two years. According to the criteria described by Odom, 
fifty-five outcomes were rated as excellent, seven were rated as 
good, thirteen were rated as fair, and eight were rated as poor. 
Functional improvements as measured with the SF-36 instru-
ment were similar to those observed in fusion studies. Radio-
graphically, the average range of flexion-extension at the site 
of the arthroplasty was 8°, although 11% of the patients had 
<2° of motion. Similar results were observed in a separate 
study of patients who had been treated with disc arthroplasty 
at two levels and in patients with myelopathy.
The two-year results associated with the Frenchay pros-
thesis (developed in Bristol, England) have been reported. 
The average range of flexion-extension was 6.5°, and the 
average anteroposterior translation was 2 mm. The clinical 
improvement also was similar to that associated with fusion. 
One patient had a revision to fusion because of loosening of 
the device.
Biological Effects of Disc Arthroplasty
Arthroplasty devices with bearing surfaces most commonly 
fail because of wear with the production of particulate matter 
and the development of an inflammatory reaction. A similar 
process is likely to occur in association with spinal prostheses. 
Hallab et al. measured inflammatory markers related to spinal 
fusion devices. The levels of tumor necrosis factor-alpha and 
the rates of cell apoptosis were increased. Furthermore, metal-
lic devices release ions that can disseminate throughout the 
body and can be identified in the serum in as many as one-
third of patients. The consequences of these findings are 
unknown.
Anderson et al. reported on the in vivo and in vitro 
wear response of the Bryan cervical disc prosthesis. After ten 
million simulated cycles, an average of 1.75% of the mass was 
lost. Elliptically shaped wear particles with a mean size of 3.8 
µm were produced. In a caprine model, the biologic effect of 
wear was assessed. In four of eleven animals, small quantities 
of wear debris were observed in the periprosthetic tissues; 
however, no inflammatory response was noted. In another 
caprine model, a different device (the Porous Coated Motion 
implant) showed excellent osseous ingrowth and no wear de-
bris or inflammatory reaction at six months postoperatively.
Patient Safety
Patient safety is increasingly being scrutinized by physicians, 
regulators, insurers, and patients themselves. Recent attention 
has been directed to the soft-tissue morbidities associated 
with the anterior approach to the cervical spine, including 
dysphagia, voice disorders, and airway obstruction. Prospec-
tive studies have shown that dysphagia is far more common 
than was previously appreciated. Persistent symptoms are 
noted in 12% to 30% of patients at one year. These rates are 
increased in patients who are managed with cervical plates 
and in women. Similarly, symptomatic vocal cord paresis is 
present in 1% to 2% of patients at one year. Reported efforts 
to protect the recurrent laryngeal nerve from iatrogenic injury 
include intraoperative electromyography and repositioning of 
the endotracheal tube by deflating and reinflating the cuff af-
ter retractor placement.
The most devastating complication is airway obstruc-
tion. Approximately 2% to 6% of patients require reintuba-
tion postoperatively. Occasionally, this is an emergent or even 
fatal situation. Variables that have been associated with an in-
creased likelihood of reintubation include prolonged opera-
tive time (more than three to five hours), the exposure of 
more cephalad levels (C2-C4), blood loss of >300 mL, a his-
tory of smoking, and other comorbidities. It has been recom-
mended that high-risk patients remain intubated until the 
swelling resolves. Steroids are used frequently but have not 
been shown to be effective in a controlled, randomized study. 
Tracheostomy should be performed if needed. A new tracheo-
stomy technique involving the use of percutaneous dilation 
has been shown to be more efficient than open surgical tra-
cheostomy in patients with a spinal cord injury.
In summary, disc replacement appears to diminish the 
adverse mechanical effects of fusion. Short-term results have 
been satisfactory, but long-term follow-up is needed to deter-
mine if the preservation of motion translates into a lower 
prevalence of adjacent-segment disease. Wear studies have 
indicated that particulate debris is produced without a sub-
stantial inflammatory effect; however, the clinical importance 
of these models has not been established. Finally, the effect of 
trauma following disc arthroplasty is unknown.
Biologic Research
One of the most active areas of study related to the spine con-
tinues to be biologic research. There is a continued effort to 
enhance bone-healing following spine fusion. With the United 
States Food and Drug Administration’s first postmarketing 
approval of a recombinant bone morphogenetic protein (rh-
BMP-2) last year, there have been continued efforts to develop 
BMPs as well as alternatives. In addition, a substantial amount 
of research continues to be focused on understanding the bio-
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logical characteristics of the intervertebral disc and on devel-
oping biological strategies to retard or reverse degeneration.
Bone-Graft Substitutes
Although preclinical and clinical trials on the use of rhBMP-7 
for spine fusion have yielded less-than-consistent results, ef-
forts are underway to utilize BMP-7 in other ways. In a study 
from the Hospital for Special Surgery, the use of an adenovi-
rus to deliver BMP-7 cDNA in bone-marrow cells was suc-
cessful in 70% of rats at eight weeks. One of the lingering 
questions regarding BMP-7 is whether its inability to achieve 
100% successful bone induction in primates is due to subopti-
mal carrier and/or dosing or whether BMP-7 is less osteoin-
ductive than some other BMPs. A study from the University 
of Chicago suggested that BMP-2, BMP-6, and BMP-9 are the 
most osteoinductive BMPs, both in vitro and in vivo. BMP-7 
appears to be less osteoinductive, especially in uncommitted 
cells. Whether this finding will have any clinical implications 
remains to be seen.
Despite a successful European pilot study, the extracted 
mixture of bovine BMPs currently is not being further devel-
oped because of budgetary constraints. The largest number of 
clinical trials on the spine that are currently underway involve 
rhBMP-2. One of the major concerns associated with rhBMP-
2 is that the dose and carrier that are currently approved by 
the Food and Drug Administration are geared for interbody 
spinal fusions inside cages and are not geared for posterolat-
eral spinal fusions. As a result, the approved kit will not pro-
vide consistent results posterolaterally. A recent study of 
nonhuman primates suggested that, with the addition of a 
bulking agent (ceramic or allograft chips) to the absorbable 
collagen sponge carrier, the currently approved dose could 
produce consistent posterolateral bone formation. Similar 
studies of humans are currently underway.
With the approval of rhBMP-2 has come an increased 
interest in lower-cost enhancers of bone-healing. Trials are 
underway to examine the selective retention of bone-marrow 
progenitor cells on osteoconductive scaffolds. While the pre-
liminary results in lower animal models have been encourag-
ing, the results of human trials are still forthcoming. The key 
question is whether a five to sevenfold concentration of the 
relatively scant numbers of mesenchymal stem cells will be 
enough to achieve spine fusion consistently in primates.
Platelet-concentration strategies have been in clinical 
use for several years, despite the lack of stringent preclinical 
data to support their use. The primary growth factors that are 
present in platelets are transforming growth factor-beta and 
platelet-derived growth factor. Neither of these cytokines are 
considered to be osteoinductive, and under certain circum-
stances both can inhibit osteoblast differentiation. Three stud-
ies suggested that one form of platelet concentrate with 
“autologous growth factors” (AGF) does not enhance bone-
healing in the spine and indeed may be inhibitory. The first 
study, from the Pennsylvania State College of Medicine, in-
volved fifty-nine patients who underwent a single-level poste-
rolateral lumbar spinal arthrodesis. The rate of radiographic 
fusion decreased from 91% when autogenous iliac crest bone 
graft was used alone to 62% when AGF was added to the 
bone graft. The second study, from the University of Louis-
ville, demonstrated that the rate of fusion was 88.2% in the 
control group and 80.3% in the AGF group (p = 0.18). The 
third study, from Tulane University, showed similar results in 
patients managed with transforaminal lumbar interbody fu-
sion. The rate of radiographic fusion was 55% in the control 
group and 46% in the AGF group (p = 0.12). None of those 
studies showed a beneficial healing effect in association with 
the use of AGF, and all showed a trend toward a lower rate of 
successful healing compared with that associated with the use 
of autograft alone.
Biological Treatments for Disc Degeneration
The second area of increased interest involves an improved 
understanding of intervertebral disc biology and the develop-
ment of animal models that will allow for the testing of strate-
gies designed to retard disc injury or degeneration. There is 
not yet a universally accepted animal model of age-related disc 
degeneration. Most models involve an acute disc injury such 
as a needle puncture with acute loss of nuclear material. In a 
rabbit study from the University of Virginia in which disc de-
generation was induced by the injection of a 30-kDa fibronec-
tin fragment, osteophytes were evident radiographically by 
twelve weeks.
It has been several years since Hanley et al. studied the 
feasibility of disc allograft transplantation in canines. A study 
from the University of Hong Kong demonstrated successful 
transplantation of fresh-frozen intervertebral disc allografts in 
seventeen rhesus monkeys. The investigators reported survival 
of the allografts with some degree of cell metabolism and mo-
bility, but they also noted severe disc degeneration by twenty-
four months. If transplantation could be combined with a 
blocker of disc degeneration, this could be an effective strategy 
for the treatment of severely degenerated discs.
A biological strategy to retard disc degeneration would 
be very useful. In a rabbit study from Rush Medical College, 
a single injection of osteogenic protein-1 (OP-1) prevented 
the loss of disc height and hydration that is normally associ-
ated with the injection of chondroitinase ABC enzyme. The 
results of that study were similar to those of another study, 
by the same authors, in which OP-1 prevented the loss of disc 
height that is normally seen after an 18-gauge needle punc-
ture. Other investigators are pursuing strategies involving the 
implantation of cells that have been culture-expanded and se-
lected. Those results are less well developed, and the technique 
is less convenient compared with the injection of a recombi-
nant protein.
Another potentially promising area of research involves 
the use of gene therapy to deliver cDNA encoding for certain 
growth factors. Various researchers have utilized the adenovi-
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rus vector to deliver a variety of anabolic and anticatabolic 
cytokines into the cells of the intervertebral disc. The theoreti-
cal advantage of gene therapy is to allow for a more sustained 
production of growth factors within the disc in order to up-
regulate matrix production or inhibit matrix catabolism. For 
example, gene transfer with use of the cDNA for rhBMP-2 and 
Sox 9 has been shown to enhance proteoglycan and collagen 
synthesis, respectively. Furthermore, a study from the Univer-
sity of Pittsburgh demonstrated that gene transfer of the cata-
bolic inhibitor TIMP-1 can increase proteoglycans in cells 
from degenerated human intervertebral discs. That study, 
along with other studies from the Pittsburgh group, suggests 
that a single cytokine may not be ideal and that a cocktail of 
anabolic and anticatabolic factors may be required for optimal 
stimulation of disc chondrocytes.
Spinal Cord Injury
Advances in the understanding and treatment of spinal cord 
injury continues to evolve at a slow but steady pace. The major 
research, as illustrated in abstracts submitted for the American 
Spinal Injury Association meeting that was held in May 2004, 
centers on understanding and modulating the secondary cas-
cade of injury following a traumatic spinal cord injury, on re-
habilitation techniques and devices for the injured patient, 
and on biological strategies for the regeneration of neural con-
nections in the injured spinal cord. 
Medical Complications of Spinal Cord Injury
Contemporary research efforts addressing the morbidities 
associated with spinal cord injury are focused on the un-
derstanding and treatment of bedsores, neuropathic pain, 
osteoporosis, and lipid-profile abnormalities. One prospec-
tive, randomized trial suggested that COX-2 inhibitors could 
be effective for the prevention of heterotopic ossification. 
Another study documented a high rate of lipid-profile and 
vitamin-D abnormalities among patients with spinal cord in-
jury and suggested that close monitoring of these parameters 
was warranted. Indium(111)-labeled leukocyte scintigraphy 
was found to be more sensitive and specific than technetium 
bone-scanning for the evaluation of severe pressure sores for 
the presence of osteomyelitis.
Neurological Recovery and Basic Science
Secondary injury occurs in the minutes and hours following 
a traumatic spinal cord injury as a result of inflammation, 
apoptosis (programmed cell death), and cytokine release, 
thereby widening the zone of injury. The prevention of sec-
ondary injury is a major focus of basic spinal cord injury re-
search. Another hot topic is the use of biological strategies to 
regenerate functional connections across the injured spinal 
cord. The p75 receptor has been shown to cause apoptosis and 
thus may be a good target for pharmacotherapy. Quercetin, a 
flavonoid, was shown to be neuroprotective by reducing apop-
tosis in a rat model. Other neuroprotective drugs are being 
studied, including Rolipram, an inhibitor of cAMP hydrolysis, 
and minocycline, an antibiotic. A new drug, HP184, which 
blocks both Na+ and K+ channels, has been tested in healthy 
volunteers and in patients with spinal cord injury. In healthy 
patients, the drug was found to be safe and well tolerated. 
Early data have suggested that this drug may improve ASIA 
motor scores following an injury. These studies have paved the 
way for wider human clinical trials.
The healing of a spinal cord lesion may be promoted by 
activated macrophages. One study evaluated human mono-
cytes that were stimulated by co-incubation with skin tissue. 
These cells were found to secrete proinflammatory cytokines, 
adhesion molecules, and high levels of CD80 and CD86, all of 
which are potentially beneficial to the injured spinal cord. 
When injected at the site of injury in ASIA-A patients within 
fourteen days after the injury, some patients demonstrated 
improvement in motor and sensory function. In rehabilitation 
medicine, early electrical stimulation of the common peroneal 
nerve was shown to improve the flexion-withdrawal response 
necessary for gait. 
Prevention
The issue of spinal cord injury prevention continues to be 
evaluated by policy makers and automobile manufacturers. 
One study evaluated the relative risk of a cervical spine injury 
to motor-vehicle occupants when using seatbelts, airbags, a 
combination of seatbelts and airbags, or no restraint system. 
The combination of seatbelts and airbags provided the great-
est protection against cervical spine injury relative to an unre-
strained occupant, with an odds ratio of 0.19. The use of a 
seatbelt alone also significantly reduced the risk of cervical 
spine injury, while the use of an airbag alone did not have any 
significant effect on the risk of a cervical spine injury. 
Spinal Cord Injury Outcomes
Both medical and surgical therapies continue to improve. Im-
aging studies have documented a strong correlation between 
the severity of a spinal cord injury and the degree of spinal 
canal compromise and spinal cord compression as seen on 
magnetic resonance imaging. A randomized clinical trial to 
determine the benefit of early surgical decompression of spi-
nal cord injuries has begun. Early surgical stabilization of the 
spine following a spinal cord injury has been shown to reduce 
medical complications and to enhance early rehabilitation, 
but the effects on neurologic recovery remain controversial. 
The ASIA motor and sensory examination has been shown to 
have high interrater reliability when used by trained examin-
ers and should be viewed as the state of the art for the neuro-
logical assessment of the patient who has a spinal cord injury. 
Although elderly patients continue to have poorer outcomes 
than younger patients, a strong multidisciplinary approach 
can produce better-than-expected outcomes in this challeng-
ing group.
Classification systems for spinal fractures continue to 
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evolve. In one study, the Denis classification was compared 
with the AO classification for thoracolumbar fractures. Only 
a moderate degree of reliability and repeatability was found in 
association with either classification system when applied to 
a group of fractures by expert spine surgeons. Less motion of 
the cervical spine was found while using a kinetic treatment 
table (RotoRest Delta; Kinetic Concepts, San Antonio, Texas) 
as compared with the standard log roll procedure in two 
separate studies. Another study compared the outcomes and 
complication profiles for patients with thoracolumbar burst 
fractures who were treated with either an anterior or posterior 
surgical approach. The group treated through an anterior 
approach sustained fewer complications, had better sagittal 
alignment, and had less pain than did the group treated 
through a posterior approach. A prospective, randomized 
study comparing anterior and posterior treatment of unilat-
eral facet injuries of the cervical spine demonstrated that the 
group that was treated through an anterior approach had bet-
ter lordosis and a higher rate of fusion, although the clinical 
outcomes were not significantly different between the groups. 
Surgical Treatment of the Lumbar Spine
Dynamic changes in the field of lumbar spine surgery contin-
ued throughout 2003. 
Surgery Outcomes
Persistent pain and dysfunction following lumbar fusion led 
investigators at State University of New York-Syracuse to 
question whether preoperative mental health testing could 
be predictive of outcomes following anterior lumbar fusion. 
Higher preoperative mental scores on the SF-36 were signifi-
cant predictors of visual analog scale back-pain ratings at 
twelve months in a study of 168 subjects who had been en-
rolled in a multiple-site trial of two fusion systems (InFix and 
BAK). Patients with a mental score of <50 had significantly 
more pain and poorer function, suggesting that a lower men-
tal health score may serve as a potential flag.
Patients with an age of more than eighteen years who 
had had lumbar spine fusion between 1991 and 1992 at the 
Twin Cities Spine Center were evaluated with regard to func-
tion, satisfaction, and the need for any additional spine sur-
gery after a minimum duration of follow-up of ten years. Of 
the 178 patients who returned a questionnaire, thirty-one 
(17%) had had adjacent-level surgery. Fusion extension was 
required for 21% of the patients in whom the index operation 
had been a posterior procedure, compared with 16% of those 
in whom the index operation had been a combined anterior-
posterior procedure. Adjacent surgery was performed for 18% 
of the patients in whom the index procedure had been per-
formed for the treatment of degenerative disc disease, com-
pared with 26% of those in whom it had been performed for 
the treatment of spondylolisthesis. Adjacent-segment exten-
sion was more commonly required when the index fusion had 
been to the sacrum (22% compared with 12%) and when de-
compression also had been done (24% compared with 15%). 
The overall rate of patient satisfaction at ten years was 70%.
One-year outcomes data from the Swedish national lum-
bar spine registry included data on 85% of all patients who had 
lumbar spine surgery in that country in 2001. The rate of pa-
tient satisfaction with surgery was 72% among patients with a 
disc herniation, 67% among patients with central spinal steno-
sis, 68% among patients with spondylolisthesis, and 61% 
among patients with degenerative disc disease. Reoperation 
within twelve months was necessary in 7% of the patients.
Trauma
Researchers at the University of Minnesota prospectively eval-
uated outcomes in patients in whom thoracolumbar burst 
fractures without an associated neurological deficit were 
treated with either anterior or posterior instrumented fusion. 
For the patients who were managed through a posterior ap-
proach, the average kyphosis was 12° at the time of admission, 
5° at the time of discharge, and 12° at the time of the twenty-
four-month follow-up. In this group, the average canal com-
promise was 39% at the time of admission and 20% at the 
time of follow-up. In the anterior fusion group, the average 
kyphosis was 13.7° at the time of admission, 2.6° at the time of 
discharge, and 3.7° at the time of follow-up. The average canal 
compromise was 40% at the time of admission and 18% at the 
time of follow-up. There were nineteen complications in six-
teen patients who had been treated posteriorly but only three 
minor complications in three patients who had been treated 
anteriorly. Although both anterior and posterior approaches 
yielded acceptable rates of patient satisfaction and return to 
work, anterior surgery alone had a lower rate of complications 
and trended toward outcomes with less pain.
Magnetic resonance imaging scans that were acquired 
for 110 patients who had back pain following an injury dem-
onstrated normal findings in only 9% of the patients and mul-
tiple-level abnormalities in 66%. Sixty-seven percent of these 
110 patients demonstrated a disc protrusion, and 5% had a 
disc extrusion. That series included fewer patients with nor-
mal findings than had been previously reported in baseline 
studies of asymptomatic patients. The rates of disc protrusion 
and extrusion in the study group were significantly higher 
than those found in baseline studies of asymptomatic patients, 
suggesting that disc pathology was a possible etiology of the 
back pain.
Artificial Disc Replacement
Investigators at the Texas Back Institute evaluated the twelve to 
twenty-four-month results for a consecutive series consisting of 
the first fifty-seven patients to receive the SB Charite disc pros-
thesis at a single center. The mean visual analog score improved 
from 69.4 preoperatively to 34.1 at six weeks and remained sta-
ble during the twenty-four months of follow-up. The mean Os-
westry disability score had improved by 40% at six weeks and by 
as much as 50% at twenty-four months. There were no in-

 TH E JO U R NA L OF BONE & JOINT SURGER Y ·  JBJS .ORG
VO LU M E 86-A ·  NU M B E R 7 ·  JU LY 2004
WH A T’S NE W I N SP I N E SURGER Y
What’s New in Spine Surgery
stances of device failure, displacement, or migration.
In another study from the Texas Back Institute, seventy-
eight patients with disabling degenerative disc disease that had 
been unresponsive to a minimum of six months of conserva-
tive treatment were randomized to surgical treatment with ei-
ther an artificial disc (ProDisc; Synthes/Spine Solutions, Paoli, 
Pennsylvania) or a 360° fusion. Fifty-four of these patients had 
one-year follow-up data. The mean visual analog and Oswe-
stry scores decreased significantly (p < 0.05) in both groups by 
six weeks postoperatively. Over time, the scores in the artificial 
disc group tended to continue to decrease whereas those in the 
fusion group remained stable. Patient satisfaction at each of 
the testing intervals was better in the artificial disc group. At 
the time of the one-year follow-up, 20% of the patients with a 
fusion stated that they would not have the surgery again 
whereas >95% of the patients with the artificial disc stated 
that they definitely would have the procedure again. None of 
the patients who had had the arthroplasty stated that they 
would refuse the operation. The clinically measured range of 
motion in terms of both forward flexion and lateral bend was 
significantly improved in the patients who had been managed 
with the ProDisc (p = 0.02). 
The range of spinal motion as measured radiographi-
cally after artificial disc replacement with use of the ProDisc 
was reported in a separate series of forty patients (fifty-seven 
levels) who had been managed at the Spine Institute at St. 
John’s Health Center in Santa Monica, California. In patients 
with a one-level artificial disc replacement, the postoperative 
range of motion was increased compared with the preopera-
tive range of motion. In patients with a two-level disc replace-
ment, the L4-L5 level showed increased motion, the L5-S1 
level showed a tendency for decreased motion, and the total 
range of motion was maintained compared with the preopera-
tive range.
Anterior Lumbar Surgery
One surgeon reported on 1315 anterior approaches to the 
lumbar spine that had been performed over a sixty-six-month 
period. Six patients had development of left iliac artery 
thrombosis, and four required thrombectomy. There were 
nineteen venous injuries to the left common iliac vein (preva-
lence, 1.4%); all were successfully repaired, with a mean blood 
loss of 650 mL. Fifteen of the venous injuries were exposures 
at the L4-L5 level.
Thirty patients who had had an anterolateral interbody 
fusion were retrospectively compared with twenty-four 
matched patients who had had a 360° fusion for the treatment 
of discogenic lumbar pain. No significant difference was found 
between the groups in terms of clinical outcome, although pa-
tients who had undergone a single-level anterolateral interbody 
fusion had improved Oswestry scores compared with patients 
who had undergone a 360° fusion (p = 0.007). However, six pa-
tients in the anterolateral interbody fusion group required revi-
sion posterior fusion because of symptomatic anterior 
nonunion. One patient in the 360° fusion group required 
revision fusion, and two additional patients required implant 
removal.
Schuler et al. attempted to determine the effect of preop-
erative disc height on clinical outcomes after a single-level ante-
rolateral interbody fusion. Patients in the “collapsed disc” 
group, who had a mean preoperative disc height of 0.5 mm, 
showed better improvement in Oswestry scores both in the 
early postoperative period and at all follow-up visits, with the 
differences in outcome becoming more pronounced over time. 
Thus, patients with the most pronounced disc-space narrowing 
showed the earliest and greatest clinical improvement.
Intradiscal Electrothermal Therapy
Investigators in Tyler, Texas, reported the results of a random-
ized placebo-controlled trial of intradiscal electrothermal 
therapy for the treatment of discogenic low-back pain. Thirty-
seven patients were allocated to intradiscal electrothermal 
therapy, and twenty-seven received sham treatment (needle 
placement to the anulus but no anular puncture and no 
thermal energy applied). Although patients in both groups 
demonstrated improvement, the mean improvement in terms 
of pain, disability, and depression was better in the intradiscal 
electrothermal therapy group. More patients in the sham 
group demonstrated deterioration over time. While approxi-
mately 40% of the patients who had been treated with intra-
discal electrothermal therapy achieved >50% relief of pain, 
approximately 50% of the patients experienced no apprecia-
ble benefit. 
Upcoming Meetings and 
Events Related to Spine Surgery
The next annual meeting of the Scoliosis Research Society 
(SRS) will be held on September 6 through 9, 2004, in Buenos 
Aires, Argentina. It will be preceded by a one-day course on 
Innovative Treatment Options in Spine Surgery, to be held on 
September 6, 2004. Web site: www.srs.org.
The Federation of Spine Associations will present the 
spine program at Specialty Day at the Annual Meeting of the 
American Academy of Orthopaedic Surgeons, to be held on 
Saturday, February 27, 2005, in Washington, DC. Web site: 
www.aaos.org.
The next annual meeting of the North American Spine 
Society (NASS) will be held on October 26 through 30, 2004, 
at the McCormick Place Convention Center, Lakeside Center, 
in Chicago, Illinois. Web site: www.spine.org.
The Twenty-second Annual Meeting of the Cervical 
Spine Research Society (CSRS) will be held on December 9 
through 12, 2004, at the Marriott Copley Place Hotel in Bos-
ton, Massachusetts. In addition, an Instructional Course will 
be held on December 11 and 12, 2004. Web site: www.csrs.org.
The meeting of the American Spinal Injury Association 
(ASIA) is the major event related to spinal cord injury medi-
cine. The next meeting will be held on May 12 through 14, 
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2005, at the Fairmont Hotel in Dallas, Texas. Web site: 
www.asia-spinalinjury.org.
Evidence-Based Orthopaedics
During 2002, the editorial staff of The Journal reviewed a large 
number of research studies related to spine surgery that received 
a Level of Evidence grade of I. Over forty medical journals were 
reviewed to identify these articles, which all have high-quality 
study design. In addition to articles published previously in this 
journal or cited already in this Update, fourteen level-I articles 
were identified that were relevant to spine surgery. A list of 
those titles is appended to this review after the standard bibliog-
raphy. We have provided a brief commentary about each of the 
articles to help to guide your further reading, in an evidence-
based fashion, in this subspecialty area.
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Evidence-Based Articles Related to Spine Surgery
Fouyas IP, Statham PF, Sandercock PA. Cochrane review on the role of sur-
gery in cervical spondylotic radiculomyelopathy. Spine. 2002;27:736-47.
The authors performed a meta-analysis in which operative and non-
operative treatment of cervical myeloradiculopathy were compared with use 
of Cochrane methodology. They identified only two randomized, controlled 
studies that met their criteria. Both studies concluded that there were no dif-
ferences in outcome variables between operatively and nonoperatively treated 
patients. The conclusion that there was no evidence to support surgical treat-
ment must be tempered. The two studies had several shortcomings, and the 
findings cannot necessarily be generalized to patients who fail to respond to 
conservative therapy and then present for surgical consideration. Also, Carl 
Sagan has stated that the absence of evidence is not evidence of absence.
Touger M, Gennis P, Nathanson N, Lowery DW, Pollack CV Jr, Hoffman JR, 
Mower WR. Validity of a decision rule to reduce cervical spine radiography in 
elderly patients with blunt trauma. Ann Emerg Med. 2002;40:287-93.
The authors retrospectively examined the efficacy of the National 
Emergency X-radiography Utilization Study (NEXUS) decision instrument to 
identify cervical spine injuries in patients more than sixty-five years of age. 
According to the NEXUS instrument, patients who are at low risk for spinal 
injury as determined on the basis of five criteria do not require radiographic 
investigation. In this study, cervical spine injuries (especially odontoid frac-
tures) were twice as frequent in elderly patients. No difference was observed 
between older and younger age-groups with regard to the performance of the 
NEXUS criteria. The NEXUS instrument had a 100% sensitivity for identify-
ing clinically important injuries in elderly patients. Although this study in-
cluded a large number of patients, inadequate descriptions of injuries and 
lack of follow-up after emergency room or hospital discharge limit the con-
clusions that can be drawn.
Kadanka Z, Mares M, Bednanik J, Smrcka V, Krbec M, Stejskal L, Chaloupka 
R, Surelova D, Novotny O, Urbanek I, Dusek L. Approaches to spondylotic 
cervical myelopathy: conservative versus surgical results in a 3-year follow-up 
study. Spine. 2002;27:2205-11.
The authors performed a prospective, randomized, controlled study of 
patients with mild cervical spondylotic myelopathy to compare the results of 
operative and nonoperative treatment. Sixty-eight patients were randomized 
to operative or nonoperative treatment and were analyzed with use of the 
Benzel myelopathy score, gait analysis, and self-evaluation. Only patients with 
mild myelopathy (as indicated by a Benzel score of ≥14) were included. No 
difference in outcome between the groups was observed at three years. The 
conclusions of the study are justified but are limited to a very narrow group of 
patients (those with mild spondylotic myelopathy). The long-term effect on 
spinal cord function if the canal is allowed to remain stenotic is unknown as 
the patients in this study had only three years of follow-up.
Hurwitz EL, Morgenstern H, Harber P, Kominski GF, Belin TR, Yu F, Adams 
AH; University of California-Los Angeles. A randomized trial of medical care 
with and without physical therapy and chiropractic care with and without 
physical modalities for patients with low back pain: 6-month follow-up out-
comes from the UCLA low back pain study. Spine. 2002;27:2193-204.
The authors reported the results of a randomized, controlled study of 
patients with more than a three-month history of low-back pain who were 
treated with chiropractic manipulation with or without physical therapy mo-
dalities. These modalities included ultrasound, heat or cold therapy, and elec-
trical stimulation. Patients were assessed at two, six, and twenty-six weeks 
with regard to pain, functional disability, and satisfaction. Significant im-
provements were seen in both treatment groups. Patients who were managed 
with physical therapy modalities performed slightly better at two and six 
weeks. However, no differences between the groups were noted at six months, 
leading to the conclusion that adjunctive physical therapy modalities do not 
improve results in patients treated with chiropractic manipulation.
Hagen KB, Hilde G, Jamtvedt G, Winnem MF. The Cochrane Review of ad-
vice to stay active as a single treatment for low back pain and sciatica. Spine. 
2002;27:1736-41.
Four trials, involving a total of 491 patients with low-back pain and 
sciatica, were selected from a database of randomized studies. In all four trials, 
patients who had been advised to stay active were compared with patients 
who had been advised to rest in bed. Only one study demonstrated signifi-
cantly better results in association with activity, but that study was thought to 
have a moderate to high risk of bias and included only male military trainees. 
Although there was no significant difference in terms of improvement in ei-
ther group, no harmful effects in terms of back pain or sciatica were identified 
in association with increased activity. 
This was a generally weak study that predominantly involved subjects 
in Europe, where different customs and disability standards make comparison 
with American patient care difficult. No strong conclusions can be drawn.
Hurwitz EL, Morgenstern H, Harber P, Kominski GF, Belin TR, Yu F, Adams 
A; University of California-Los Angeles. A randomized trial of medical care 
with and without physical therapy and chiropractic care with and without 
physical modalities for patients with low back pain: 6-month follow-up out-
comes from the UCLA low back pain study. Spine. 2002;27:2193-204.
In this study, patients who were members of health maintenance orga-
nizations and who presented with back pain agreed to be randomized to one 
of four treatment groups. Of 1469 eligible patients, 681 were enrolled. After 
six months of follow-up, chiropractic care and medical care for low-back pain 
were deemed to be comparable in terms of the changes in pain intensity and 
disability. There were no significant differences in disability time, days in bed, 
or medication usage between the groups.
The weaknesses of this study included the patients’ ability to self-
enroll, the failure to recruit >50% of eligible patients, and the “captive” nature 
of patients in a health maintenance organization system, which may limit ex-
trapolation of these results to a more general population of patients who have 
the ability to change services if they are unhappy with their progress.
Petersen T, Kryger P, Ekdahl C, Olsen S, Jacobsen S. The effect of McKenzie 
therapy as compared with that of intensive strengthening training for the 
treatment of patients with subacute or chronic low back pain: a randomized 
controlled trial. Spine. 2002;27:1702-9.
In this study from Denmark, 260 patients with chronic back pain (de-
fined as back pain of at least eight weeks’ duration) were randomized to treat-
ment with McKenzie exercises performed under the supervision of a physical 
therapist or group exercises that included supervised dynamic strengthening. 
In both groups, patients received a maximum of fifteen treatments over eight 
weeks and then participated in a self-administered program for an additional 
two months before assessment. No significant differences were found between 
the two groups in terms of disability. Pain tended to be lower in the McKenzie 
group at two months, but the difference was not significant. 
As 30% of the patients in both groups withdrew from the study, and as 
there was no untreated control group, it is difficult to draw any meaningful 
conclusion from this report.
Cardenas DD, Warms CA, Turner JA, Marshall H, Brooke MM, Loeser JD. 
Efficacy of amitriptyline for relief of pain in spinal cord injury: results of a 
randomized controlled trial. Pain. 2002;96:365-73.
The authors describe the results of the first placebo-controlled, 
double-blind, prospective, randomized study evaluating the efficacy of a 
tricyclic antidepressant, amitriptyline, for the treatment of chronic pain 
following a spinal cord injury. The mechanism of action of amitriptyline is 
through the selective reuptake inhibition of serotonin and norepinephrine. It 
has been hypothesized that pain relief occurs as a result of central and periph-
eral pain-inhibition mechanisms. Tricyclic antidepressants have been found 
to be effective for relieving discomfort in patients with migraine headaches, 
fibromyalgia, atypical facial pain, and diabetic neuropathy. Their benefit in 
the treatment of dysesthetic pain in patients with spinal cord injury has never 
been demonstrated, although they frequently are used for this purpose. In this 
study, intent-to-treat analysis did not support the use of amitriptyline when it 
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was compared with an active placebo, benztropine mesylate, for the relief of 
pain. This finding is important because spine surgeons often choose this med-
ication for the treatment of chronic neuropathic pain and pain associated 
with degenerative disc disease although its efficacy has never truly been con-
firmed in a prospective, randomized study. In fact, only one previous study 
has evaluated the effect of this medication in the treatment of pain associated 
with spinal cord injury, and that study also did not support its efficacy. The 
investigation by Cardenas et al. is a well-designed study and represents the 
largest clinical trial to date evaluating the use of a medication for the treat-
ment of chronic pain in the setting of spinal cord injury.
Bracken MB. Methylprednisolone and acute spinal cord injury: an update of 
the randomized evidence. Spine. 2001;26(24 Suppl):547-54.
The authors of this study performed a systematic review with use of 
Medline, CINAHL, and the Cochrane Library to determine the effectiveness 
of methylprednisolone in the treatment of acute spinal cord injury. The lead 
author has been the lead investigator in three National Acute Spinal Cord In-
jury studies (NASCIS). These studies have demonstrated that the administra-
tion of high-dose methylprednisolone within eight hours after an acute spinal 
cord injury is safe and is modestly effective for improving functional outcome 
following a spinal cord injury. These data have come under criticism over the 
last several years because the intent-to-treat groups in the NASCIS II and III 
studies showed no significant neurological improvement with methylpred-
nisolone and only after a post ad-hoc analysis did a subgroup of patients show 
improvement in motor scores. To date, the United States Food and Drug Ad-
ministration has not approved the use of high-dose methylprednisolone for 
the treatment of spinal cord injury. In the spinal community, this medication 
is generally recommended because a better alternative is not available, because 
it involves minimal cost, and because it may be effective in certain patient 
subgroups if given early. The search continues for an optimum pharmacologi-
cal intervention that may ultimately modify or alter the secondary injury cas-
cade following a spinal cord injury. 
Ishida Y, Tominaga T. Predictors of neurologic recovery in acute central cervi-
cal cord injury with only upper extremity impairment. Spine. 2002;27:1652-8.
The authors of this study observed that patients who had a central 
cord syndrome that involved impairment of motor and sensory function of 
only the upper extremities but who had no evidence of abnormal changes to 
the cervical spinal cord on magnetic resonance imaging often responded well 
to nonoperative treatment, with substantial neurological recovery after six 
weeks of follow-up. The authors did not study patients with a dense central 
cord syndrome that involved impairment of both upper and lower extremity 
function. It is clear that patients who show substantial recovery and have mild 
deficits without instability following a spinal cord injury respond favorably to 
nonoperative intervention. The pressing issue is the degree of aggressiveness 
(i.e., surgical intervention) that should be afforded to a patient with both up-
per and lower extremity dysfunction in the setting of a dense central cord syn-
drome. Should certain parameters be defined in which surgical intervention is 
not in the patient’s best interest, as in the case of an elderly patient with multi-
ple comorbidities or a patient with severe motor impairment? Such questions 
can only be answered through controlled, prospective, randomized studies, 
which are necessary to provide a better understanding of the natural history 
of all degrees of central cord syndromes.
Fritzell P, Hägg O, Wessberg P, Nordwall A; Swedish Lumbar Spine Study 
Group. Chronic low back pain and fusion: a comparison of three surgical 
techniques: a prospective multicenter randomized study from the Swedish 
lumbar spine study group. Spine. 2002;27:1131-41.
This was a multicenter, randomized study with a two-year follow-up. 
Over a six-year time-period, 294 patients who had been referred to nineteen 
spinal centers were blindly randomized into four treatment groups. Three 
groups were treated operatively, and one was treated nonoperatively. The op-
erative procedures were (1) posterolateral fusion, (2) posterolateral fusion 
with pedicle screws, and (3) posterolateral fusion with pedicle screws and in-
terbody fusion. All surgical techniques were found to reduce pain and to de-
crease disability substantially, but there were no significant differences among 
the groups with respect to clinical outcome. The overall fusion rate was 72% 
in group 1, 87% in group 2, and 91% in group 3.
Gibson S, McLeod I, Wardlaw D, Urbaniak S. Allograft versus autograft in in-
strumented posterolateral lumbar spinal fusion: a randomized control trial. 
Spine. 2002;27:1599-603.
This study from Scotland evaluated the clinical outcomes for sixty-
nine patients who had been managed with instrumented lumbar fusion. The 
patients were randomized to receive either their own bone (harvested from 
the iliac crest) or allograft bone (fresh-frozen bone obtained from the femoral 
head at the time of total hip arthroplasty). The same surgeon performed all 
procedures, and Steffee plates were used for all patients. Thirty-seven patients 
received allograft bone, and thirty-two received their own bone. The allograft 
bone was thawed at the time of surgery and was morselized with use of a man-
ually operated bone mill in the operating room. On the basis of Roland and 
Morris scores at the time of the one-year evaluation, the two groups were 
identical when the patients with donor-site pain were excluded. The fusion 
rates in both groups were somewhat unclear, and the authors did state that the 
results deteriorated over time. Furthermore, at the time of “long-term follow-
up,” they stated that 33% of the patients in the allograft group and 40% of 
those in the autograft group had no improvement in their scores or had a 
poor result. This article points out the morbidity that is associated with har-
vesting bone from the iliac crest. However, without a better assessment of fu-
sion status, it is hard to truly compare the two groups. We know that implants 
often will maintain immobilization without failure for two to five years post-
operatively.
Furlan AD, Brosseau L, Imamura M, Irvin E. Massage for low-back pain: a 
systematic review within the framework of the Cochrane Collaboration Back 
Review Group. Spine. 2002;27:1896-910.
In an effort to assess the effects of massage therapy for nonspecific 
low-back pain, the authors assessed nine publications describing eight ran-
domized trials. The authors concluded that massage might be beneficial for 
patients with subacute and chronic non-specific low-back pain, especially 
when combined with exercises and education. However, the results of the 
eight trials were not strongly conclusive. A large-volume, multicenter, pro-
spective, randomized study probably would be needed to truly answer the 
question regarding the effectiveness of massage therapy compared with other 
nonoperative modalities in the treatment of lumbar back pain.
Hofstee DJ, Gijtenbeek JM, Hoogland PH, van Houwelingen HC, Kloet A, 
Lötters F, Tans JT. Westeinde sciatica trial: randomized controlled study of bed 
rest and physiotherapy for acute sciatica. J Neurosurg. 2002;96(1 Suppl):45-9.
In this study from The Netherlands, the investigators attempted to 
compare the efficacies of three nonoperative treatment strategies for patients 
with sciatica. The three methods were bed rest, physiotherapy, and continua-
tion of activities of daily living. The analysis of the primary and secondary 
outcome measures showed no significant differences among the three treat-
ment groups. Neither bed rest nor physiotherapy had a more favorable effect 
on recovery from sciatica than did continuation of activities of daily living. 
This article from the neurosurgery literature seems to confirm what has been 
published in orthopaedic literature.
